Baader Bank Aktiengesellschaft’s Regeneron Pharmaceuticals REGN Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$928K	Sell	1,488 -5,323	-78%	-$3.62M	0.07%	196
2026 Q1	$5.26M	Buy	6,811 +3,958	+139%	+$3.03M	0.41%	58
2025 Q4	$2.2M	Buy	2,853 +291	+11%	+$198K	0.15%	108
2025 Q3	$1.44M	Sell	2,562 -11,727	-82%	-$6.63M	0.09%	139
2025 Q2	$7.5M	Buy	+14,289	New	+$7.98M	0.54%	48
2025 Q1	–	Sell	-866	Closed	-$617K	–	483
2024 Q4	$617K	Sell	866 -79	-8%	-$66.3K	0.04%	206
2024 Q3	$992K	Sell	945 -22	-2%	-$24.5K	0.06%	181
2024 Q2	$1.01M	Buy	967 +262	+37%	+$254K	0.06%	176
2024 Q1	$679K	Sell	705 -35	-5%	-$33.3K	0.05%	202
2023 Q4	$648K	Sell	740 -19	-3%	-$15.6K	0.05%	181
2023 Q3	$622K	Buy	759 +29	+4%	+$22.8K	0.04%	190
2023 Q2	$525K	Sell	730 -99	-12%	-$76.3K	0.03%	243
2023 Q1	$678K	Buy	829 +19	+2%	+$14.3K	0.03%	217
2022 Q4	$584K	Hold	810	–	–	0.03%	254
2022 Q3	$558K	Sell	810 -240	-23%	-$151K	0.04%	255
2022 Q2	$621K	Sell	1,050 -230	-18%	-$150K	0.05%	245
2022 Q1	$894K	Hold	1,280	–	–	0.07%	148
2021 Q4	$808K	Buy	+1,280	New	+$787K	0.06%	186

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Baader Bank Aktiengesellschaft's REGN Position: Q2 2026 in Review

Baader Bank Aktiengesellschaft reduced its Regeneron Pharmaceuticals (REGN) stake by 78% in Q2 2026, selling an estimated $3.62M and leaving 1,488 shares worth $928K. The position accounts for 0.07% of the portfolio, ranked #196.

Baader Bank Aktiengesellschaft first reported a position in REGN in Q4 2021 and has held it in 18 quarters since. The position peaked at $7.5M in Q2 2025. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Baader Bank Aktiengesellschaft held 1,488 shares of Regeneron Pharmaceuticals worth $928K as of Q2 2026.
Baader Bank Aktiengesellschaft sold 5,323 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $3.62M.
Regeneron Pharmaceuticals made up 0.07% of Baader Bank Aktiengesellschaft's portfolio in Q2 2026, its #196 holding.
Baader Bank Aktiengesellschaft first reported a position in Regeneron Pharmaceuticals in Q4 2021 and has held it in 18 quarters since.
Baader Bank Aktiengesellschaft's Regeneron Pharmaceuticals position peaked at $7.5M in Q2 2025.
1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q2 2026, filed 23 Jul 2026.